My research focuses on two primary areas: 1) improving the care and treatment of underserved cancer patients using cancer genetics and genomics research and technologies and 2) the role of non-coding mutations in cancer by studying the mechanism of action of TERT promoter mutations in cancer.
I work at the intersection of cancer genetics, global health, and domestic and global cancer disparities. I am conducting research on the tumor genetics of prostate cancer in African-American men. In addition, I am leading efforts in global oncology research through the Global Cancer Project Map (gcpm.globalonc.org) and working to improve and enable collaborations to improve cancer research and treatment in low- and middle-income countries.
I am a physician-scientist and a member of the Genitourinary Oncology division at the Dana-Farber Cancer Institute. I serve as mentor to students and trainees who are interested in cancer disparities, genetics, and global oncology. I am also the co-founder of Global Oncology (www.globalonc.org).